Načítá se...
Economic evaluation of first-line and maintenance treatments for advanced non-small cell lung cancer: a systematic review
During these last years, there have been an increased number of new drugs for non-small cell lung cancer (NSCLC), with a growing financial effect on patients and society. The purpose of this article was to review the economics of first-line and maintenance NSCLC treatments. We reviewed economic anal...
Uloženo v:
Vydáno v: | Clinicoecon Outcomes Res |
---|---|
Hlavní autoři: | , , , |
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
Dove Medical Press
2014
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4271788/ https://ncbi.nlm.nih.gov/pubmed/25548525 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S43328 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|